192 related articles for article (PubMed ID: 14631560)
21. Goodpasture's disease: a report of ten cases and a review of the literature.
Dammacco F; Battaglia S; Gesualdo L; Racanelli V
Autoimmun Rev; 2013 Sep; 12(11):1101-8. PubMed ID: 23806563
[TBL] [Abstract][Full Text] [Related]
22. Goodpasture antigen of the glomerular basement membrane: localization to noncollagenous regions of type IV collagen.
Wieslander J; Barr JF; Butkowski RJ; Edwards SJ; Bygren P; Heinegård D; Hudson BG
Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3838-42. PubMed ID: 6328527
[TBL] [Abstract][Full Text] [Related]
23. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition.
Ryan JJ; Mason PJ; Pusey CD; Turner N
Clin Exp Immunol; 1998 Jul; 113(1):17-27. PubMed ID: 9697978
[TBL] [Abstract][Full Text] [Related]
24. Study of EHS type IV collagen lacking Goodpasture's epitope in glomerulonephritis in rats.
Bolton WK; Luo AM; Fox PL; May WJ; Sturgill BC
Kidney Int; 1995 Feb; 47(2):404-10. PubMed ID: 7536854
[TBL] [Abstract][Full Text] [Related]
25. Anti-GBM antibodies in Goodpasture syndrome; anatomy of an epitope.
Hellmark T; Segelmark M; Wieslander J
Nephrol Dial Transplant; 1997 Apr; 12(4):646-8. PubMed ID: 9140985
[No Abstract] [Full Text] [Related]
26. Advances in human antiglomerular basement membrane disease.
Cui Z; Zhao MH
Nat Rev Nephrol; 2011 Jul; 7(12):697-705. PubMed ID: 21769105
[TBL] [Abstract][Full Text] [Related]
27. Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity.
Cui Z; Zhao MH
Clin Immunol; 2005 Jul; 116(1):77-82. PubMed ID: 15925834
[TBL] [Abstract][Full Text] [Related]
28. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
Brainwood D; Kashtan C; Gubler MC; Turner AN
Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
[TBL] [Abstract][Full Text] [Related]
29. A self T cell epitope induces autoantibody response: mechanism for production of antibodies to diverse glomerular basement membrane antigens.
Wu J; Arends J; Borillo J; Zhou C; Merszei J; McMahon J; Lou YH
J Immunol; 2004 Apr; 172(7):4567-74. PubMed ID: 15034074
[TBL] [Abstract][Full Text] [Related]
30. Human antiglomerular basement membrane autoantibody disease in XenoMouse II.
Meyers KE; Allen J; Gehret J; Jacobovits A; Gallo M; Neilson EG; Hopfer H; Kalluri R; Madaio MP
Kidney Int; 2002 May; 61(5):1666-73. PubMed ID: 11967016
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of antibodies in Goodpasture syndrome reacting with type IV collagen.
Kefalides NA; Ohno N; Wilson CB
Kidney Int; 1993 Jan; 43(1):85-93. PubMed ID: 7679459
[TBL] [Abstract][Full Text] [Related]
32. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen.
Rutgers A; Meyers KE; Canziani G; Kalluri R; Lin J; Madaio MP
Kidney Int; 2000 Jul; 58(1):115-22. PubMed ID: 10886555
[TBL] [Abstract][Full Text] [Related]
33. Recurrent Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1/alpha2 chains of type IV collagen.
Borza DB; Chedid MF; Colon S; Lager DJ; Leung N; Fervenza FC
Am J Kidney Dis; 2005 Feb; 45(2):397-406. PubMed ID: 15685519
[TBL] [Abstract][Full Text] [Related]
34. Role of regulatory T cells in experimental autoimmune glomerulonephritis.
Klinge S; Yan K; Reimers D; Brede KM; Schmid J; Paust HJ; Krebs CF; Panzer U; Hopfer H; Mittrücker HW
Am J Physiol Renal Physiol; 2019 Mar; 316(3):F572-F581. PubMed ID: 30648909
[TBL] [Abstract][Full Text] [Related]
35. Entactin: a possible auto-antigen in the pathogenesis of non-Goodpasture anti-GBM nephritis.
Saxena R; Bygren P; Butkowski R; Wieslander J
Kidney Int; 1990 Aug; 38(2):263-72. PubMed ID: 2119467
[TBL] [Abstract][Full Text] [Related]
36. Characterization of anti-GBM antibodies involved in Goodpasture's syndrome.
Hellmark T; Johansson C; Wieslander J
Kidney Int; 1994 Sep; 46(3):823-9. PubMed ID: 7527877
[TBL] [Abstract][Full Text] [Related]
37. Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies.
Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
J Am Soc Nephrol; 2007 Apr; 18(4):1338-43. PubMed ID: 17329569
[TBL] [Abstract][Full Text] [Related]
38. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease.
Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
Nephrol Dial Transplant; 2009 Jun; 24(6):1838-44. PubMed ID: 19151145
[TBL] [Abstract][Full Text] [Related]
39. Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies.
Hellmark T; Burkhardt H; Wieslander J
J Biol Chem; 1999 Sep; 274(36):25862-8. PubMed ID: 10464328
[TBL] [Abstract][Full Text] [Related]
40. Different immunologic properties of the globular NC1 domain of collagen type IV isolated from various human basement membranes.
Weber M; Pullig O
Eur J Clin Invest; 1992 Feb; 22(2):138-46. PubMed ID: 1374033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
